Podcasts about Intuitive Surgical

Unser Partner Scalable Capital ist der einzige Broker, den deine Familie zum Traden braucht. Bei Scalable Capital gibt's nämlich auch Kinderdepots. Alle weiteren Infos gibt's hier: scalable.capital/oaws. Tesla verfehlt Erwartungen. Anthropic kauft von Google. IBM, L'Oréal, Hermès wachsen, Aktien fallen trotzdem. Kering schrumpft weniger. Teamviewer senkt Prognose. Adidas erhöht Prognose. SAP fällt wegen Cloud-Segment. 11.000 Roboter von Intuitive Surgical (WKN: 888024) operieren weltweit. Im letzten Quartal hat die Firma die Erwartungen übertroffen, doch Analysten warnen vor aufstrebenden Konkurrenten. Morgan Stanley (WKN: 885836) will seine Kryptostrategie anpassen und nicht nur Großkunden Zugang zu Bitcoin und Co. geben. Das könnte Kryptowährungen mehr Akzeptanz bringen - was bringt es der Morgan-Stanley-Aktie? Diesen Podcast vom 23.10.2025, 3:00 Uhr stellt dir die Podstars GmbH (Noah Leidinger) zur Verfügung.

In this episode, Scott highlights Intuitive Surgical's strong growth, GM's record quarter, Netflix's steady success, and more.

In this episode, Scott highlights Intuitive Surgical's strong growth, GM's record quarter, Netflix's steady success, and more.

Die seit gestern Abend gemeldeten Ergebnisse sind gemischt, bis leicht positive ausgefallen. Wir sehen nach den Zahlen bei insbesondere Intuitive Surgical deutliche Kursgewinne. Auch die Aktien von Capital One, GE Vernova, Hilton und AT&T tendieren nach den Ergebnissen freundlich. Abgabedruck sehen wir wegen verfehlter Ertragszahlen und belasteter Margen bei vor allem Netflix, wie auch bei Texas Instruments wegen der flauen Aussichten. Nach dem Closing werden die Ergebnisse von vor allem IBM und Tesla viel Beachtung finden. Auf der Macro-Ebene bleibt es unruhig. Donald Trump lässt offen, ob ein Treffen mit Chinas Xi am 31. Oktober tatsächlich stattfinden wird. Außerdem will Trump mit den Demokraten erst dann sprechen, wenn der Shutdown aufgehoben wird. Die Lager bleiben hier anscheinend weiter gespalten. Abonniere den Podcast, um keine Folge zu verpassen! ____ Folge uns, um auf dem Laufenden zu bleiben: • X: http://fal.cn/SQtwitter • LinkedIn: http://fal.cn/SQlinkedin • Instagram: http://fal.cn/SQInstagram

Die seit gestern Abend gemeldeten Ergebnisse sind gemischt, bis leicht positive ausgefallen. Wir sehen nach den Zahlen bei insbesondere Intuitive Surgical deutliche Kursgewinne. Auch die Aktien von Capital One, GE Vernova, Hilton und AT&T tendieren nach den Ergebnissen freundlich. Abgabedruck sehen wir wegen verfehlter Ertragszahlen und belasteter Margen bei vor allem Netflix, wie auch bei Texas Instruments wegen der flauen Aussichten. Nach dem Closing werden die Ergebnisse von vor allem IBM und Tesla viel Beachtung finden. Auf der Macro-Ebene bleibt es unruhig. Donald Trump lässt offen, ob ein Treffen mit Chinas Xi am 31. Oktober tatsächlich stattfinden wird. Außerdem will Trump mit den Demokraten erst dann sprechen, wenn der Shutdown aufgehoben wird. Die Lager bleiben hier anscheinend weiter gespalten. Ein Podcast - featured by Handelsblatt. +++ Alle Rabattcodes und Infos zu unseren Werbepartnern findet ihr hier: https://linktr.ee/wallstreet_podcast +++ +++ Hinweis zur Werbeplatzierung von Meta: https://backend.ad-alliance.de/fileadmin/Transparency_Notice/Meta_DMAJ_TTPA_Transparency_Notice_-_Ad_Alliance_approved.pdf +++ Der Podcast wird vermarktet durch die Ad Alliance. Die allgemeinen Datenschutzrichtlinien der Ad Alliance finden Sie unter https://datenschutz.ad-alliance.de/podcast.html Die Ad Alliance verarbeitet im Zusammenhang mit dem Angebot die Podcasts-Daten. Wenn Sie der automatischen Übermittlung der Daten widersprechen wollen, klicken Sie hier: https://datenschutz.ad-alliance.de/podcast.html Impressum: https://www.360wallstreet.de/impressum

Healthcare schwächelt, doch Arne Briest bleibt gelassen. Der Manager des Wikifolio Healthcare Demografie setzt weiter auf Robotik, Biotech und Medizintechnik. "Der demografische Wandel ist voll im Laufen – der Trend bleibt intakt", sagt Briest. Kurzfristige Dellen durch Trump, Kosten und Regulierung ändern für ihn nichts am Kurs: "Verwerfungen haben Vorteile - der Markt verdaut und adjustiert sich."

Dr. Vishwa Srivastava, APAC CEO of SSI, SS Innovations International, is a leader in telesurgery, using robotic surgery to extend surgical services in underserved areas. The SSI Mantra surgical robot is used for laparoscopic surgery and offers an affordable alternative to prevailing robotic solutions without compromising quality. Telesurgery has potential in remote operations and is also revolutionizing surgical training by providing real-time expert proctoring. Vishwa explains, "My father was one of the early global pioneers in robotic cardiac surgery, and he had actually helped Intuitive Surgical back in their early days get their FDA approval. And what he recognized very quickly was that through these minimally invasive robotic cardiac surgical procedures, 20% of his patients went home the next day, 50% in two days or less, and the average length of stay was 3.2 days. So, he became convinced after they twisted his arm to launch robotic cardiac surgical programs. And Dr. Fred Moll at the time was the chairman and founder of Intuitive Surgical, and he wanted to start on the heart because it was the most complex procedure to do a beating heart, totally endoscopic, bypass surgery. And he felt that if you could do that, then everything else would be simple."   "The way that we look at remote robotic surgery, or what we call telesurgery, currently, we are the only company in India that has received formal regulatory approval from the CDSCO for both teleproctoring and telesurgery. The way that we look at teleproctoring and telesurgery, it's not like one rockstar surgeon sitting in one location operating omnipresent in a hundred different locations." "With teleproctoring and telesurgery, the way that we look at it is in addition to operating and extending expertise in the remote areas of the country, we look at teleproctoring and telesurgery the same way that doctors are trained in residency where you always have an attending in the room, the junior surgeon will be operating, and the goal of the proctor or the attending surgeon is to guide the junior surgeon to maturity."  #SSInnovations #RoboticSurgery #Telesurgery #CardiacProcedures #HeartSurgery #Teleproctoring #RemoteSurgery  SSInnovations.com Download the transcript here

Dr. Vishwa Srivastava, APAC CEO of SSI, SS Innovations International, is a leader in telesurgery, using robotic surgery to extend surgical services in underserved areas. The SSI Mantra surgical robot is used for laparoscopic surgery and offers an affordable alternative to prevailing robotic solutions without compromising quality. Telesurgery has potential in remote operations and is also revolutionizing surgical training by providing real-time expert proctoring. Vishwa explains, "My father was one of the early global pioneers in robotic cardiac surgery, and he had actually helped Intuitive Surgical back in their early days get their FDA approval. And what he recognized very quickly was that through these minimally invasive robotic cardiac surgical procedures, 20% of his patients went home the next day, 50% in two days or less, and the average length of stay was 3.2 days. So, he became convinced after they twisted his arm to launch robotic cardiac surgical programs. And Dr. Fred Moll at the time was the chairman and founder of Intuitive Surgical, and he wanted to start on the heart because it was the most complex procedure to do a beating heart, totally endoscopic, bypass surgery. And he felt that if you could do that, then everything else would be simple."   "The way that we look at remote robotic surgery, or what we call telesurgery, currently, we are the only company in India that has received formal regulatory approval from the CDSCO for both teleproctoring and telesurgery. The way that we look at teleproctoring and telesurgery, it's not like one rockstar surgeon sitting in one location operating omnipresent in a hundred different locations." "With teleproctoring and telesurgery, the way that we look at it is in addition to operating and extending expertise in the remote areas of the country, we look at teleproctoring and telesurgery the same way that doctors are trained in residency where you always have an attending in the room, the junior surgeon will be operating, and the goal of the proctor or the attending surgeon is to guide the junior surgeon to maturity."  #SSInnovations #RoboticSurgery #Telesurgery #CardiacProcedures #HeartSurgery #Teleproctoring #RemoteSurgery  SSInnovations.com Listen to the podcast here

In der heutigen Folge sprechen die Finanzjournalisten Anja Ettel und Holger Zschäpitz über einen Gamechanger-Deal, Wall-Street-Rekorde trotz Shutdown und das fulminante Börsendebüt von Fermi. Außerdem geht es um Pfizer, Merck, Eli Lilly, Novo Nordisk, Vertex, Regeneron, Thermo Fisher, Repligen, Danaher, Boston Scientific, Abbott, Intuitive Surgical, Bayer, Merck, Salzgitter, Thyssenkrupp, Bitcoin, Solana, Ether, Sartorius, Palantir Technologies, Thales, L3Harris Technologies, RTX, Kratos Defense & Security Solutions, AeroVironment, DroneShield, Elbit Systems, Electro Optic Systems, Saab AB, Hensoldt, Mercury Systems, QinetiQ, Chemring Group, Cohort, Exail Technologies, Rocket Lab, Iridium Communications, BlackSky Technology, Electro Optic Systems, Leidos Holdings, CACI International, Parsons, Telos Corp, Leidos, SAIC, QinetiQ, Parsons VanEck Space Innovators ETF (WKN: A3DP9J), Invesco Defence Innovation ETF (WKN: A40J95), Global X Defence Tech ETF (WKN: A40E7A), Droneshield, Palantir, Red Cat Holdings. Wir freuen uns über Feedback an aaa@welt.de. Noch mehr "Alles auf Aktien" findet Ihr bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts und AAA-Newsletter. Hier bei WELT: https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html. Der Börsen-Podcast Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? Hier findest du alle Infos & Rabatte! https://linktr.ee/alles_auf_aktien Impressum: https://www.welt.de/services/article104636888/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

What separates good managers from leaders people line up to work for? In this energizing conversation, host Anusha sits down with Whitney Faires—internationally recognized coach, keynote speaker, and former senior executive at Intuitive Surgical who helped scale a $2B business line—to unpack the Courageous Leader Roadmap. Whitney shares the “Sunday-night test” for honest self-assessment, explains why people-first leadership outperforms results-only management, and reframes fearless communication as a practice of refusing to let fear decide what gets said—not saying everything that crosses your mind.You'll learn how to identify your leadership archetype, build judgment and self-awareness in high-stakes moments, and consistently access your power zone using personal activators (and guarding against depletors). Whitney also talks candidly about navigating guilt, competing priorities, and career pivots you didn't choose—plus how to reclaim agency by focusing on what you can control and designing growth inside any role.Whether you're managing your first team or scaling a division, this episode gives you practical prompts, mindset shifts, and repeatable routines to raise your game—and your team's.Connect with Whitney on LinkedIn or Instagram (@whitney_faires) and join her mailing list for upcoming workshops and group coaching opportunities.Thank you to Gies College of Business for Sponsoring this Podcast. Want to be considered for the podcast? Send an email to ashton@ellevatenetwork.com with your topic focus and a short bio.To learn more about Ellevate Network and how we're building a community that supports women+ at every stage of their careers, visit ellevatenetwork.com or reach out to info@ellevatenetwork.com.

This week, we revisit our conversation with Keith Grossman. Keith has been a leader in the medical technology industry for more than 35 years. He was the Chairman of the Board of Nevro Corporation (NVRO) until April 2025, having previously served as President and CEO from 2019 to April 2023. Prior to Nevro, he was named President and CEO of Thoratec Corp. (THOR) for the second time in 2014. He led the company's return to growth, a 2.5x increase in company value, and its $3.4 billion acquisition by St. Jude Medical in 2015. He previously served as the CEO, President, and Director of Conceptus, Inc. (CPTS) from 2011 to 2013, where he took the company from negative sales growth to over 20% growth, tripled EBIDTA, and led the company's sale to Bayer Healthcare for over $1.1 billion, a 3x increase in the company's value before his arrival. Prior to Conceptus, Keith served as managing director of TPG (Texas Pacific Group), a private equity firm, as a member of its healthcare investment team. Prior to TPG, Mr. Grossman served as Thoratec's President, Chief Executive Officer, and director for the first ten years of its growth as a commercial company.  Prior to Thoratec, he held a number of commercial and general management roles with companies including SulzerMedica and American Hospital Supply Corp. He currently also serves as Vice Chairman of Alcon, Inc., and is on the board of Outset Medical, Inc. and previously served as a member of the Board of directors of Intuitive Surgical, Inc., Kyphon, Inc., ViewRay, Inc., Zeltiq, Inc, and a number of privately held medical device companies. Keith received a B.S. in life sciences from The Ohio State University and an M.B.A. from Pepperdine University.

Miguel Méndez, analista de mercados ha analizado la situación del mercado. Sobre Iberdrola, Méndez ha sido claro: “Me está aburriendo un poco últimamente”. En contraste, ha señalado que Endesa le está gustando más actualmente por su comportamiento en el mercado. En cuanto a valores estadounidenses, ha dicho que Ulta Beauty, “lo está haciendo muy bien” y actualmente se encuentra “testeando la resistencia” tras superar un largo periodo bajista de casi dos años. Por otra parte, Intuitive Surgical fue uno de los nombres destacados del consultorio: “Tienen algo que prácticamente es único en el mercado. En el ámbito nacional, Banco Sabadell también fue protagonista. Méndez ha sido tajante: “He escuchado esta mañana al CEO de Sabadell y yo, si fuese inversor, vendería las acciones”, pese a que el valor se ha multiplicado por 10 o 12 desde 2020. Por último, ha mostrado una visión positiva sobre Repsol, asegurando que “lo ha hecho muy bien” y que, lejos de recomendar su venta, sugiere mantenerla en cartera con un stop en los 13,90 euros.

Find out who our gold, silver, and bronze winners are this week. We'll take a look at earnings from General Motors, Intuitive Surgical, and Enphase Energy, and we will also discuss the recent tariff deal struck between the US and Japan. Companies mentioned: GM, ISRG, ENPH Host: Travis Hoium Guests: Lou Whiteman, Matt Frankel Learn more about your ad choices. Visit megaphone.fm/adchoices

Welcome to a new episode of the EUVC podcast, where Dan Bowyer and Mads Jensen of SuperSeed and Lomax from Outsized Ventures, gather to unpack the macro forces and micro signals shaping European tech and venture.This week, the trio tackles one of the most geopolitically charged, capital-heavy, and morally complex episodes yet:

Send us a textDr. Forrest Ringold, MD of Surgical Association of Mobile ( https://sampadocs.com/about-us/dr-forrest-ringold/ ), is a leading expert in bariatric and robotic surgery and is renowned for his expertise in transforming lives through weight loss surgery and innovative abdominal treatments.With an advanced understanding of both traditional laparoscopic techniques and cutting-edge robotic technology, Dr. Ringold specializes in a wide range of surgical procedures aimed at improving the health and quality of life of his patients, including life-changing weight loss surgeries such as sleeve gastrectomy, gastric bypass, duodenal switch, SADI, and lap band, as well as pioneering advancements in reflux surgery and esophageal and stomach diseases.As a leading authority in his field, Dr. Ringold serves as a key opinion leader for both Intuitive Surgical and Teleflex Medical ( https://www.teleflex.com/usa/en/index.html ), two of the most respected names in medical devices. His innovative approach extends to the latest in gastrointestinal surgery, where he is actively pursuing groundbreaking advancements in magnetic anastomotic technology.Dr. Ringold's commitment to excellence extends beyond patient care. He is a clinical instructor at the University of South Alabama's Department of Surgery, where he shares his wealth of knowledge with the next generation of surgeons. His dedication to his craft is also reflected in his leadership roles, including his current position as President of the Alabama State Chapter of the American Society for Metabolic and Bariatric Surgery.Since 2018, Dr. Ringold has led the Epicenter at Mobile Infirmary Medical Center, a distinguished program designed to train surgeons nationwide in the fields of robotic and bariatric surgery.Dr. Ringold attended medical school at University of South Alabama Medical School and did his residency in general surgery at University of South Alabama Medical Center.#ForrestRingold #SurgicalAssociationOfMobile #Bariatric #RoboticSurgery #WeightLossSurgery #SleeveGastrectomy #GastricBypass #DuodenalSwitch #LapBand #MagneticAnastomoticTechnology #TeleflexMedical #SouthAlabamaMedicalSchool #ObesitySurgery #PostoperativeReflux #DeNovoGastroesophagealRefluxDisease #GERD #TitanSGSStapler #SurgicalStaplers #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #ResearchSupport the show

Welcome to a new episode of the EUVC podcast, where Dan Bowyer and Mads Jensen of SuperSeed and Lomax from Outsized Ventures gather to unpack the macro forces and micro signals shaping European tech and venture.This week, the trio tackles one of the most geopolitically charged, capital-heavy, and morally complex episodes yet:The global reshuffling of power: Israel, Iran, Russia, and UkraineWhy defense is back—and what it means for VCsEurope's space ambitions and what the ESA's new satellite project signalsChina's trade plays and Europe's vulnerability in rare earthsAI, IPOs, and why founders might want to stay private longerSurgical robots, ambient AI, and who's building the future of healthcarePlus: Daniel Ek gets flak, SPACs sneak back, and why VCs are now speed-running $15B deals in one week.Here's what's covered:02:00 War & Markets: Iran, Israel, oil prices & Bank of England holds06:00 Defense Budgets: Why Europe is (finally) spending10:00 VC Taboo: Why investing in weapons gets complicated fast15:00 EIF Restrictions: Sex, gambling, and no defense20:00 The Rise of Helsing: Europe's $12B defense unicorn24:00 Strategic Autonomy: Europe's new military satellite constellation30:00 ESA vs. Starlink: Earth observation gets serious34:00 China, Trade Wars & Rare Earths: Why Europe's exposed40:00 EU-US Tariffs & Trump's Pharma Threat42:00 IPO Boom: Chime, Circle, and the SPAC comeback47:00 CMR Surgical: UK's $4B robot exit—is that enough?53:00 Lessons from Intuitive Surgical & deeptech M&A56:00 Deal of the Week: Nabla's AI for clinicians, Helsing, and Scale AI's lightning-fast cash01:02:00 Founders in Government: Alex DePledge & Matt Clifford's impact01:05:00 Meta's AI Transfers: Zuck goes full football transfer window

Whitney Faires is an internationally recognized coach, keynote speaker, and leadership strategist who empowers her clients to overcome obstacles and achieve extraordinary levels of performance with greater fulfillment. She spent 16 years at Intuitive Surgical, where she led global leadership development and helped scale a $2B business line. Now she helps high achievers—especially those ready for something more—pivot into values-aligned leadership roles with clarity and confidence. A leading authority in developing high-performing teams and coaching industry executives worldwide, she focuses on helping people master their mindset to unlock their full potential and thrive both personally and professionally. In this episode Whitney and Christa cover the importance of personal growth, overcoming self-doubt, and the significance of building a supportive network! Website: whitneyfaires.com LinkedIn: https://www.linkedin.com/in/whitney-faires-14955a38/ Instagram: @whitney_faires Keywords: coaching, personal development, self-doubt, career transition, support network, entrepreneurship, leadership, empowerment, growth, mentorship Takeaways: **Whitney transitioned from a corporate career to coaching to fulfill her passion for helping others grow. **High performers often seek more than just financial success; they crave impact and fulfillment. **Creating a supportive environment is crucial for pe achieving your career goals. **Building a business while still employed can provide the confidence needed to make a career leap. **It's essential to have a clear plan and understanding of your value before transitioning careers. **Mentorship and accountability are vital for navigating career changes successfully. **Follow-through on commitments to mentors is crucial for maintaining valuable relationships. **Finding the right fit with a coach or mentor can significantly impact your growth journey. Chapters 00:00 The Journey to Coaching: A Personal Transformation 12:03 Overcoming Self-Doubt and Embracing Change 18:11 Building a Supportive Network and Finding Your Tribersonal and professional growth.

If your doctor is recommending that you get a mastectomy, you will likely have some choices about how the surgery is performed. Your breast cancer treatment, your body, your breast shape and your lifestyle affect not only your options, but also the pros and cons of your options. There's no one method that works best for everyone because each person is unique. Today we are going to be exploring one specific type of mastectomy – the nipple-sparing mastectomy. This is a skin-sparing mastectomy that leaves the nipple and areola intact and usually improves the overall look of the reconstructed breast. Joining us on the show today are two very special guests: Dr. Mara Piltin, a Breast and Melanoma Surgical Oncologist and Physician Assistant, Maddie Beiswanger, both from Mayo Clinic. They are going to tell us more about nipple-sparing mastectomy procedures, current research that is being conducted around the use of minimally invasive robotic surgery to assist in these procedures and the possible benefits that these innovations can provide. This episode of The Real Pink Podcast is brought to you by Intuitive Surgical. Intuitive is a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery. Intuitive has been advancing minimally invasive care since 1995 with the goal of helping physicians improve the lives of people around the world. You can learn more at www.Intuitive.com

Alphabet's ad business keeps putting up huge numbers, but a DOJ breakup, generative AI threats, and potential macro slowdown loom. (00:21) Jason Moser and Asit Sharma discuss: - Alphabet's resilient ad business, and what parts of the company might be most interesting if the break-up happens. - Tesla's rough quarter, and why the Model Y release is a key moment for the company's auto thesis. - Chipotle's burrito slowdown, how ServiceNow's government contracts are holding up, and the latest with Intuitive Surgical. (19:11) Malcolm Ethridge comes back on the show to talk big tech and his favorite recession-proof stocks. (34:48) Asit and Jason break down two stocks on their radar: Nasdaq and Adobe. Stocks discussed: GOOG, GOOGL, TSLA, NOW, ISRG, ACN, NFLX, SPOT, NDAQ, ADBE. Host: Dylan Lewis Guests: Jason Moser, Asit Sharma, Malcolm Ethridge Engineers: Dan Boyd Learn more about your ad choices. Visit megaphone.fm/adchoices

Follow along and subscribe/rate/review at https://www.briancovey.com/podcast/In this episode of The Competitive Edge, Brian Covey welcomes high-performance coach Kristy Kuhl, whose journey from a one-stoplight town to corporate sales superstar and now elite coach serves as a blueprint for self-alignment and transformation.Kristy shares her transition from the high-stress world of medical device sales — notably with Intuitive Surgical's da Vinci robot — to a more purpose-driven life centered on coaching. Her story is a powerful reminder that success without alignment can lead to burnout. Kristy introduces listeners to the power of Human Design, situational leadership, and the role of fitness in mental clarity and peak performance.Together, Brian and Kristy unpack strategies for building self-awareness, curating your circle of influence, and creating a life and career in sync with your values. From navigating social media with intention to developing platforms that serve others authentically, this episode is packed with tools and takeaways for leaders, entrepreneurs, and anyone ready to grow.Tune in for an inspiring and practical conversation that will challenge you to look inward, take aligned action, and surround yourself with the right people to elevate your game.

  During this Episode, Russ discusses the Large Unprotected Covered Call or L.U.C.C trading strategy.  Large in that the share price is large (think Costco, Netflix, Intuitive Surgical, etc.).  Unprotected in the sense that the strategy doesn't buy insurance in  a protective put option at a lower price (like a collar trade).  It is essentially a large, In The Money (“ITM”) covered call.  It is protected from volatility and the large upfront cost by how far down in the money you select, and you give back some of the premium (the intrinsic value portion) - though give back is a misnomer in that it all happens automatically at the brokerage.  Several examples are given.    Don't forget to subscribe to the show!

Get 25% off an annual membership with this link: https://ko-fi.com/chipstockinvestor/link/MARKETMELTDOWN25In this episode of Chip Stock Investor, we dive into fresh earnings reports from two robotics-heavyweights: Tesla and Intuitive Surgical. Is Tesla's Q1 dip a normal cycle downturn or the start of something bigger? We explore key data points like vehicle deliveries, energy revenue, and Elon's political impact. Then we turn to Intuitive Surgical's solid performance, procedure growth, and how tariffs might affect its margins. Two very different businesses, both navigating big challenges and big opportunities.Sign Up For Our Newsletter: https://mailchi.mp/b1228c12f284/sign-up-landing-page-short-formJoin us on Discord with Semiconductor Insider: https://ko-fi.com/chipstockinvestor/tiersSupercharge your analysis with AI! Get 15% of your membership with our special link here: https://finchat.io/csi/Safeguard your personal information with Aura's monitoring service – try it free for two weeks and see where your data might be lurking: https://aura.com/chipstockinvestor

Carson Group's Ryan Detrick and Payne Capital's Courtney Garcia break down today's huge rally, with the major averages regaining all of Monday's big losses. A packed slate of earnings led by Tesla. Wedbush's Dan Ives and former Tesla President Jon McNeill give instant reaction to the EV-maker's numbers. On the macro front, Jefferies' David Zervos discusses Fed policy and the latest Trump vs. Powell tensions. Other earnings include Enphase, Baker Hughes, Capital One, Intuitive Surgical and SAP. Plus, Morgan gives key takeaways from defense sector earnings. 

In this episode of Medsider Radio, we sat down with Ryan Rhodes, CEO of EDAP TMS. EDAP is changing prostate cancer treatment through Focal One, a robotic high-intensity focused ultrasound (HIFU) system that doesn't require the use of surgery or radiation. Ryan has over 30 years of experience in market development, with two decades focused on medical robotics. Before EDAP, Ryan was CEO of Restoration Robotics, where he guided the company to a successful merger with Venus Concept. He spent 13+ years at Intuitive Surgical, establishing the global Urology franchise, which became the company's entry point for broader adoption of the da Vinci system. He also spent 11 years at Ethicon (J&J) in sales, marketing, and market development.In this interview, Ryan challenges founders to ask: Are you creating a scalable medtech solution or a product with limited growth potential? He unpacks why standardization and scalability are critical for adoption, how clinical data fuels credibility and reimbursement, and why early adopters take the biggest risks — but also reap the biggest rewards.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Ryan Rhodes.

In this week's Digital Health Roundup, Medtech Insight's Marion Webb highlights her interview with Gary Guthart, CEO of Intuitive Surgical about the new da Vinci 5 surgical robot and the future of robotics in surgery. Brian Bossetta talks about the recently FDA-cleared patient monitoring system that sends vital signs directly to clinician staff. Elizabeth Orr discusses an FDA warning letter to Exer Labs and Shubham Singh discusses Roche's new NGS Prototype, expected to challenge Illumina.

Eric Veiel, head of Global Investments and CIO at T. Rowe Price Associates, chats with Gary Guthart, CEO of Intuitive Surgical, about advancements in robotic surgery, the company's expanding ecosystem, and his journey to becoming CEO.

March 31, 2025 | Season 5 | Episode 11The weakening US dollar may be the canary in the coal mine for broader market troubles ahead. Despite conditions that should strengthen it—high interest rates, geopolitical uncertainty, America's military dominance—the greenback has fallen against nearly every major global currency in 2025. This unusual pattern suggests foreign investors are losing confidence, potentially withdrawing the capital that traditionally supports US stocks and bonds.Meanwhile, markets are bracing for what President Trump calls "Liberation Day" on April 2nd, when new tariff policies are expected. Reports of a possible 20% universal tariff on all imports have sent tremors through Wall Street, with Goldman Sachs cutting its S&P target twice this month. The potential $11,000 price increase on imported vehicles illustrates the real-world impact these policies could have on consumers and businesses alike.The artificial intelligence sector appears to be entering a crucial transition phase where investors demand tangible returns on massive investments. Drawing fascinating parallels to the 1990s internet boom, experts remind us that only 1% of today's internet giants existed just 2.5 years after Netscape Navigator launched. Today's market leaders may not be tomorrow's AI champions, suggesting opportunities in companies like Snowflake, Intuitive Surgical, and cybersecurity firms that will protect increasingly vulnerable AI systems.For fixed income investors, discussions about potentially eliminating municipal bond tax exemptions to fund Trump tax cut extensions present both risk and opportunity. While concerning, municipal bonds have already priced in some of this uncertainty, potentially creating value for long-term investors willing to weather the volatility.As we navigate these complex market currents, watch the dollar's trajectory carefully—it may tell us more about where markets are heading than traditional economic indicators. What signals are you watching as we enter this period of heightened uncertainty?** For informational and educational purposes only, not intended as investment advice. Views and opinions are subject to change without notice. For full disclosures, ADVs, and CRS Forms, please visit https://heroldlantern.com/disclosure **To learn about becoming a Herold & Lantern Investments valued client, please visit https://heroldlantern.com/wealth-advisory-contact-formFollow and Like Us on Youtube, Facebook, Twitter, and LinkedIn | @HeroldLantern

Vous ne savez pas dans quoi investir en Bourse ? Des gérants vous donnent des idées de valeurs, secteurs, matières premières... Aujourd'hui, c'est Guillaume Di Pizio, responsable de la gestion chez Dauphine AM.

On the first call since Kroger CEO Rodney McMullen's departure, not a mention of the former CEO was heard. (00:21) Nick Sciple and Ricky Mulvey discuss: - Kroger's business results. - Why some investors are becoming more pessimistic about Abercrombie & Fitch. - A small-cap tobacco company playing in a fast-growing trend. Then, (17:22) Karl Thiel joins Mary Long to discuss advanced-robotics company, Intuitive Surgical. Companies discussed: KR, ANF, TPB, ISRG, GOOG, GOOGL Host: Ricky Mulvey Guests: Nick Sciple, Mary Long, Karl Thiel Engineers: Dan Boyd, Rick Engdahl Learn more about your ad choices. Visit megaphone.fm/adchoices

Join us on Discord with Semiconductor Insider:https://ko-fi.com/chipstockinvestor/tiersOur "forever healthcare stock" Intuitive Surgical had a great 2024. Is it too late to buy in 2025? Chip Stock Investor Kasey Rossolillo discusses recent advances with the da Vinci surgical robot, why the stock always seems expensive, but why it remains a favorite for the long term.Supercharge your analysis with AI! Get 15% of your membership with our special link here:https://finchat.io/csi/Safeguard your personal information with Aura's monitoring service – try it free for two weeks and see where your data might be lurking:https://aura.com/chipstockinvestor

In this episode, Scott Becker examines the struggles of major healthcare stocks like HCA, Universal Health Services, and Intuitive Surgical amid concerns over healthcare reimbursement and cost containment.

In this episode, Scott Becker examines the struggles of major healthcare stocks like HCA, Universal Health Services, and Intuitive Surgical amid concerns over healthcare reimbursement and cost containment.

In der heutigen Folge von „Alles auf Aktien“ sprechen die Finanzjournalisten Anja Ettel und Philipp Vetter über knappe Kassen bei Nikola, den Puma-Absturz und eine Achterbahnfahrt bei Intuitive Surgical. Wir freuen uns an Feedback über aaa@welt.de. Ab sofort gibt es noch mehr "Alles auf Aktien" bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts und AAA-Newsletter.[ Hier bei WELT.](https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html.) [Hier] (https://open.spotify.com/playlist/6zxjyJpTMunyYCY6F7vHK1?si=8f6cTnkEQnmSrlMU8Vo6uQ) findest Du die Samstagsfolgen Klassiker-Playlist auf Spotify! Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. Außerdem bei WELT: Im werktäglichen Podcast „Das bringt der Tag“ geben wir Ihnen im Gespräch mit WELT-Experten die wichtigsten Hintergrundinformationen zu einem politischen Top-Thema des Tages. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? [**Hier findest du alle Infos & Rabatte!**](https://linktr.ee/alles_auf_aktien) Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

Rafael Ojeda, analista independiente, pone el foco en Verizon, American Express, Intuitive Surgical, Texas Instruments y Boeing.

European bourses are mixed, tech-heavy NQ slightly underperforms after SK Hynix highlights demand concerns.USD flat with price action contained in quiet trade; markets await US President Trump at Davos.Bonds hold a bearish bias into Trump though benchmarks bounced briefly on strong UK & French supply, but returned to session lows.Crude a little firmer, Base metals continue to be subdued by Trump tariff threats.Looking ahead, US Initial Jobless Claims, Australian PMI, Japanese CPI, Canadian Retail Sales, CBRT Policy Announcement, Supply from the US, Speakers including SNB Chair Schlegel & US President Trump.Earnings from GE Aerospace, American Airlines Group Inc., Freeport-McMoRan Copper & Gold, Huntington Bancshares Incorporated, Texas Capital Bancshares, Elevance Health, Alaska Air Group, Union Pacific Corp., Texas Instruments Incorporated, Intuitive Surgical, CSX Corp.Read the full report covering Equities, Forex, Fixed Income, Commodites and more on Newsquawk

Miramos a valores como American Airlines, Freeport McMoran, Electronic Arts, Intuitive Surgical y Texas Instruments. Con Rafael Damborenea, profesor de finanzas en Eude Bussines School.

Unser Partner Scalable Capital ist der einzige Broker, den du brauchst. Inklusive Trading-Flatrate, Zinsen und Portfolio-Analysen. Alle weiteren Infos gibt's hier: scalable.capital/oaws. Aktien + Whatsapp = Hier anmelden. Lieber als Newsletter? Geht auch. Das Buch zum Podcast? Jetzt lesen. Zinsen fallen endlich. Goldman Sachs, Citigroup, Wells Fargo und BlackRock steigen trotzdem. Denn IB war 2024 profitabel möglich. Ansonsten planen SGS & Bureau Veritas eine Giga-Fusion, Bayer verliert und gewinnt Rechtsstreit & Intuitive Surgical wächst. McDonald's (WKN: 856958) hatte ein schlechtes 2024. Ein neuer Giga-Deal in Südamerika, kostenlose Tinder-Abos für Kunden und ein Double Cheeseburger für 1 $ sollen's richten. Rumble (WKN: A3DRQQ) ist irgendwo zwischen MicroStrategy und Truth Social. Was dafür spricht: Giga-Investments, Deals mit El Salvador, krasse Investoren. Was dagegen spricht: Harte Zahlen. Diesen Podcast vom 16.01.2025, 3:00 Uhr stellt dir die Podstars GmbH (Noah Leidinger) zur Verfügung.

Alissa Coram and Ed Carson analyze Wednesday's market action and discuss key stocks to watch on Stock Market Today.

Alissa Coram and Justin Nielsen analyze Monday's market action and discuss key stocks to watch on Stock Market Today.

Where does Iman Jeddi see Intuitive's da Vinci 5 - and robotics - fit into the future of surgery? In this episode of IntuitiveTalks, Iman Jeddi, PhD, senior vice president and general manager of the company's multi port platform, shares a vision for the future of surgery where robotic systems elevate the performance of surgeons and deliver greater care equity. Jeddi's career started in biomedical engineering, taking her through several start-ups and ultimately, Abbott. Her lifelong career goal to create technology that improved care for the many led her to join Intuitive Surgical in 2013. Jeddi has held multiple leadership roles in engineering, operations, and quality. Prior to taking her current post, Jeddi was general manager of the single-port platform, da Vinci SP, so she brings a uniquely comprehensive perspective to the company's surgical robotic portfolio. The interview begins and ends with a personal story illustrating her belief in building medical devices and tools that can deliver better care for as many patients as possible. Thank you to Aptyx for sponsoring this episode of IntuitiveTalks! Please visit www.aptyx.com to learn more about how Aptyx can help you manufacture your competitive edge. Thank you for listening to the IntuitiveTalks Podcast. Subscribe to this podcast on every major podcast platform.

Ed Carson and Alissa Coram walk through Tuesday's market action and discuss key stocks to watch in Stock Market Today.

In this episode, Scott Becker discusses the latest successes of Apple, Amazon, and Intuitive Surgical, highlighting strong performances under exceptional leadership. From Apple’s record revenues to Amazon’s impressive earnings and Intuitive’s standout growth, Scott shares insights on what makes these CEOs and companies ones to watch.

In this episode, Scott Becker discusses the latest successes of Apple, Amazon, and Intuitive Surgical, highlighting strong performances under exceptional leadership. From Apple’s record revenues to Amazon’s impressive earnings and Intuitive’s standout growth, Scott shares insights on what makes these CEOs and companies ones to watch.

In this episode, Scott Becker covers Netflix’s impressive turnaround, Intuitive Surgical’s strong performance, CVS’s CEO change and stock dip, and American Express’s slight drop despite a strong year. Listen for insights on these key market moves and more.

In this episode, Scott Becker covers Netflix’s impressive turnaround, Intuitive Surgical’s strong performance, CVS’s CEO change and stock dip, and American Express’s slight drop despite a strong year. Listen for insights on these key market moves and more.

In this insightful episode of the Global Medical Device Podcast, host Etienne Nichols is joined by Simon Mason, President of NEST (National Evaluation System for Health Technology), to explore how real-world evidence (RWE) is shaping the future of medical device regulation. Simon breaks down NEST's critical role in catalyzing the use of RWE to streamline submissions, accelerate time-to-market, and lower costs for MedTech companies. With a focus on post-market data, off-label use, and pivotal test cases like pediatric devices and robotic surgery, this conversation reveals the immense potential of RWE to improve patient outcomes and advance medical innovation. Simon also touches on the evolution of NEST since its creation under the FDA's MDUFA commitment and provides real-world examples of how RWE has led to FDA clearances, including collaborations with industry giants like Johnson & Johnson and Intuitive Surgical.Key Timestamps:[00:02:05] – Introduction to Simon Mason and NEST's mission.[00:06:30] – The importance of real-world evidence in medical device submissions.[00:10:50] – NEST's relationship with FDA and industry stakeholders.[00:18:25] – Real-world examples: How RWE led to device clearances.[00:25:10] – Challenges in using real-world data for submissions.[00:32:45] – NEST's role in pediatric devices and the potential for off-label approvals.[00:38:30] – The financial and time-saving benefits of using real-world evidence.[00:50:00] – How companies can engage with NEST to accelerate device approvals.Quotes:Simon Mason: “Real-world evidence has the potential to accelerate device approval and save millions in clinical trial costs. It's all about leveraging existing data to support regulatory submissions.”Etienne Nichols: "The opportunity to use off-label real-world data to expand indications opens a whole new world of innovation for MedTech companies."Simon Mason: “Speed is everything in business and in patient care. RWE is all about moving faster while maintaining safety and effectiveness.”Key Takeaways:Latest MedTech Trends:Real-World Evidence (RWE) Revolution: RWE is transforming regulatory pathways by utilizing data already being collected in real-world settings, reducing the need for costly clinical trials.Off-Label Use for Approvals: NEST is helping companies harness off-label data, particularly in pediatric and robotic surgery, to expand product indications.FDA Collaboration: NEST serves as a bridge between the FDA and industry, simplifying the regulatory process for device companies.Practical Tips for MedTech Innovators:Engage Early: Medical device companies should consider engaging with NEST early in their product lifecycle to identify potential RWE opportunities.Data Accessibility: Companies should explore existing registries or datasets that could support their submissions, saving time and resources.Clear Project Goals: When approaching NEST, companies should have a clear understanding of their product claims and the available data to support them.Questions for Future Development:How will the widespread adoption of RWE change the landscape for early-stage MedTech startups?Can RWE become the default pathway for medical device approvals, replacing traditional clinical trials?What role will AI play in streamlining data collection and analysis for real-world evidence?References:

In der heutigen Folge von „Alles auf Aktien“ sprechen die Finanzjournalisten Anja Ettel und Holger Zschäpitz über das beste 3. Quartal seit Jahren, Gewinnwarnungen bei Luxus- und Massenkarren und einen durchwachsenen Ausblick der Aida-Aktie. Außerdem geht es um Fedex, UPS, C.H. Robinson Worldwide, ZIM Integrated Shipping, Moller-Maersk, Hapag-Lloyd, CSX, Norfolk Southern, Garmin, Apple, Samsung, DexCom, Global X Internet of things (WKN: A2QPB1), ishares Automation und Robotics (WKN: A2H5ES), Workday, Autodesk, Intuitive Surgical, Constellation, Stellantis, Ashton Martin, Nio und Carnival. Wir freuen uns an Feedback über aaa@welt.de. Ab sofort gibt es noch mehr "Alles auf Aktien" bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts und AAA-Newsletter. Hier bei WELT: https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html. Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. Außerdem bei WELT: Im werktäglichen Podcast „Das bringt der Tag“ geben wir Ihnen im Gespräch mit WELT-Experten die wichtigsten Hintergrundinformationen zu einem politischen Top-Thema des Tages. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? Hier findest du alle Infos & Rabatte! https://linktr.ee/alles_auf_aktien Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

In this episode, Scott discusses stock performance of major companies like Macy’s, Intuitive Surgical, and Tempus AI, alongside insights into job cuts at big names like Cisco and Google. Plus, a look at the delicate balance of inflation control, strategic business advice, and more.

In this episode of the Canadian Investor Podcast, we dive into the latest trends and insights shaping the market. First, have a look at the TD Direct Investing Index which shows that investor sentiment is slightly bearish despite markets hitting all time highs. We look at the stocks that have been the most bought and sold by TD's self-directed investors with some surprise names on the list. Switching gears, we share the results of a Twitter poll on the best personal finance hacks. We then talk about a listener's question on when to trim a core position due to high valuation multiples, using Intuitive Surgical as a case study.   Lastly, we explore the concept of battleground stocks—those highly volatile and polarizing stocks that attract both passionate bulls and bears. Using examples like Tesla, Palantir, and Disney, we discuss the risks and rewards of investing in these contentious equities and share lessons learned from their market behavior. Tickers of Stocks & ETF discussed: TSLA, PLTR, DIS, NVDA, GME, TD, BCE.TO, SHOP.TO, AAPL, T.TO, SMCI, AMD Check out our portfolio by going to Jointci.com Our Website Canadian Investor Podcast Network Twitter: @cdn_investing Simon's twitter: @Fiat_Iceberg Braden's twitter: @BradoCapital Dan's Twitter: @stocktrades_ca Want to learn more about Real Estate Investing? Check out the Canadian Real Estate Investor Podcast! Apple Podcast - The Canadian Real Estate Investor  Spotify - The Canadian Real Estate Investor  Web player - The Canadian Real Estate Investor Sign up for Finchat.io for free to get easy access to global stock coverage and powerful AI investing tools. Register for EQ Bank, the seamless digital banking experience with better rates and no nonsense.See omnystudio.com/listener for privacy information.

The post-Covid surgery backlog is fueling Intuitive Surgical to strong preliminary earnings results, and the CEO of Burford Capital talks through their unique niche in the legal space. (00:21) Jason Moser and Dylan Lewis discuss: - The SEC's pending decision on crypto spot ETFs and the agency's X account getting hacked. - Potential regulations coming for the gig economy and workers that are heavily reliant on companies like Uber, Lyft, and DoorDash. - An early earnings look for Intuitive Surgical, and why surgery activity has normalized post-COVID. (12:48) Burford Capital CEO Chris Bogart walks analyst Rich Griefner through the world of legal financing, his company's competitive advantages, and a high-stakes case with Argentina. Companies discussed: UBER, LYFT, DASH, AMXZN, BUR Host: Dylan Lewis Guests: Jason Moser, Rich Griefner, Engineers: Dan Boyd, Dez Jones Learn more about your ad choices. Visit megaphone.fm/adchoices